Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study
/in Breast Cancer, Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2008-11-08 / Cancer Immunol. Immunother. 2009 Jun;58(6):887-900Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients
/in Cervical Cancer, International Publications /von 2008-11-05 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):242-50[Activation of anti-tumor cytotoxic T lymphocytes by fusion of human dendritic cells and melanoma cells]
/in International Publications, Malignant Melanoma /von 2008-11-01 / Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008 Nov;33(11):1012-8Dendritic cell vaccines for the treatment of prostate cancer
/in International Publications, Prostate Cancer /von 2008-11-01 / Urol. Oncol. 2008 Nov-Dec;26(6):576-80Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo
/in Dendritic Cells, International Publications /von 2008-10-25 / Cancer Immunol. Immunother. 2009 Jun;58(6):901-13The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells
/in International Publications, Malignant Melanoma /von 2008-10-23 / Exp. Dermatol. 2009 Apr;18(4):396-403Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2008-10-18 / Neurol. Res. 2009 Feb;31(1):3-10Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model
/in International Publications, Malignant Melanoma /von 2008-10-08 / Clin. Immunol. 2008 Dec;129(3):482-91The anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK/GCV induced dying cells
/in Hepatocellular Carcinoma, International Publications /von 2008-10-02 / Cell. Immunol. 2009;254(2):135-41
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de